Literature DB >> 1924058

Massive chloroquine overdose--a survivor.

G Stiff1, D Robinson, H L Cugnoni, R Touquet, A M Dalton.   

Abstract

Large chloroquine overdoses are almost inevitably fatal. We describe the presentation and management of a patient with such an overdose who survived, due to general supportive care and new specific treatment.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1924058      PMCID： PMC2399061          DOI： 10.1136/pgmj.67.789.678

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  5 in total

1.  Protective cardiovascular effects of diazepam in experimental acute chloroquine poisoning.

Authors:  B Riou; A Rimailho; M Galliot; R Bourdon; Y Huet
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

2.  The effects of acute chloroquine poisoning with special reference to the heart.

Authors:  T A Don Michael; S Aiwazzadeh
Journal:  Am Heart J       Date:  1970-06       Impact factor: 4.749

3.  Experimental assessment of the protective activity of diazepam on the acute toxicity of chloroquine.

Authors:  J Crouzette; E Vicaut; S Palombo; C Girre; P E Fournier
Journal:  J Toxicol Clin Toxicol       Date:  1983-05

4.  Chloroquine serum concentration and side effects: evidence for dose-dependent kinetics.

Authors:  M Frisk-Holmberg; Y Bergkvist; B Domeij-Nyberg; L Hellström; F Jansson
Journal:  Clin Pharmacol Ther       Date:  1979-03       Impact factor: 6.875

5.  Disposition of chloroquine in man after single intravenous and oral doses.

Authors:  L L Gustafsson; O Walker; G Alván; B Beermann; F Estevez; L Gleisner; B Lindström; F Sjöqvist
Journal:  Br J Clin Pharmacol       Date:  1983-04       Impact factor: 4.335
  5 in total
  3 in total

1.  Delayed therapeutic hypothermia following cardiac arrest secondary to chloroquine toxicity.

Authors:  George Mark Haslam; Matt C Thomas; Stephen R Laver
Journal:  BMJ Case Rep       Date:  2009-03-06

2.  Chloroquine dosage regimens in patients with COVID-19: Safety risks and optimization using simulations.

Authors:  Vangelis Karalis; George Ismailos; Eleni Karatza
Journal:  Saf Sci       Date:  2020-05-21       Impact factor: 4.877

Review 3.  Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties.

Authors:  Cornelis Smit; Mariska Y M Peeters; John N van den Anker; Catherijne A J Knibbe
Journal:  Clin Pharmacokinet       Date:  2020-06       Impact factor: 6.447
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.